Results
1 -
4 of
4Sun Daqing, Li Zhihong, Rew Yosup, Gribble Michael, Bartberger Michael D., Beck Hilary P., Canon Jude, Chen Ada, Chen Xiaoqi, Chow David, Deignan Jeffrey, Duquette Jason, Eksterowicz John, Fisher Benjamin, Fox Brian M., Fu Jiasheng, Gonzalez Ana Z., Gonzalez-Lopez De Turiso Felix, Houze Jonathan B., Huang Xin, Jiang Min, Jin Lixia, Kayser Frank, Liu Jiwen (Jim), Lo Mei-Chu, Long Alexander M., Lucas Brian, McGee Lawrence R., McIntosh Joel, Mihalic Jeff, Oliner Jonathan D., Osgood Tao, Peterson Matthew L., Roveto Philip, Saiki Anne Y., Shaffer Paul, Toteva Maria, Wang Yingcai, Wang Yu Chung, Wortman Sarah, Yakowec Peter, Yan Xuelei, Ye Qiuping, Yu Dongyin, Yu Ming, Zhao Xiaoning, Zhou Jing, Zhu Jiang, Olson Steven H., Medina Julio C..
Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development, Journal of Medicinal Chemistry, 2014 Ribeiro Carlos J. A., Amaral Joana D., Rodrigues Cecília M. P., Moreira Rui, Santos Maria M. M..
Spirooxadiazoline oxindoles with promising in vitro antitumor activities, Med. Chem. Commun., 2016 J. Truong, A. George, J. K. Holien.
10